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Cosmid B577, a member of the collection of ordered clones corresponding to the genome of Mycobacterium
leprae, contains a gene, provisionally called pon1, that encodes an 821-amino-acid-residue high-molecular-mass
class A penicillin-binding protein, provisionally called PBP1. With similar amino acid sequences and modular
designs, M. leprae PBP1 is related to Escherichia coli PBP1a and PBP1b, bienzymatic proteins with transgly-
cosylase and transpeptidase activities. When produced in E. coli, His tag-labelled derivatives ofM. leprae PBP1
adopt the correct membrane topology, with the bulk of the polypeptide chain on the surface of the plasma
membrane. They defy attempts at solubilization with all the detergents tested except cetyltrimethylammonium
bromide. The solubilized PBP1 derivatives can be purified by affinity chromatography on Ni21-nitrilotriacetic
acid agarose. They have low affinities for the usual penicillins and cephalosporins.
Synthesis of the bacterial wall peptidoglycan involves a set of
membrane-bound monofunctional (low-molecular-mass) and
multimodular (high-molecular-mass) penicillin-binding pro-
teins (PBPs) and an assortment of cell cycle proteins that do
not bind penicillin (7). The PBP patterns of Mycobacterium
smegmatis (1) and Mycobacterium fortuitum (5) have been de-
scribed elsewhere, and a low-molecular-mass PBP of M. smeg-
matis has been studied.
Mycobacterium leprae, the causative agent of leprosy, is an
obligatory intracellular gram-positive bacillus. It is not cultiva-
ble, and it has an extremely long generation time of 2 weeks or
more in experimentally infected animals. An M. leprae gene
project has been launched, the aim of which is to obtain an
ordered cosmid library that covers the entire chromosome and,
ultimately, to obtain the complete nucleotide sequence (3, 6,
10, 16).
As shown below, cosmid B577 (3), after correction for a
frameshift, contains a gene, provisionally called pon1, that en-
codes a class A multimodular PBP. M. leprae PBP1 has been
produced in Escherichia coli, and its properties were studied.
MATERIALS AND METHODS
Strains, oligonucleotides, and plasmids. The transformations were carried out
in E. coli DH5a. The expression of the modified pon1 genes was carried out in
E. coli BL21 (DE3). Oligonucleotides A, B, and C (Fig. 1) were from Pharmacia,
Biotech Benelux, Roosendaal, The Netherlands.
The plasmids (Fig. 2) were constructed as follows.
(i) pDML901. Cosmid B577 was amplified in E. coli DH5a and digested with
BamHI and EcoRI, and the excised 6,078-bp fragment was cloned into the
high-copy-number pUC18. pDML901 served as the source of the M. leprae
PBP1-encoding pon1.
(ii) pDML904. pET-28a(1) (Novagen, Madison, Wis.) was digested with NdeI
and NotI, and the excised 72-bp fragment was replaced by oligonucleotide A.
(iii) pDML905. pDML901 was digested with BamHI and ScaI, and the excised
3,232-bp fragment (purified with the Gibco BRL Life Technologies Glassmax
kit) was digested partially with HindIII. The 2,698-bp HindIII-ScaI fragment
(encoding the truncated PBP1 devoid of the 14 amino-terminal amino acid
residues) was inserted between HindIII and ScaI into pDML904.
(iv) pDML906. The DraIII-AlwNI segment of pET-22b(1) (Novagen) con-
taining the ampicillin resistance determinant was replaced by the DraIII-AlwNI
segment of pET-28a(1) containing the kanamycin resistance determinant, yield-
ing pET22b/kan. The 67-bp MscI-XhoI segment of pET22b/kan was replaced by
oligonucleotide B.
(v) pDML907. pDML905 was digested with EcoRV (with elimination of the
segment encoding the 39 amino-terminal amino acid residues of PBP1) and RsrII
(with elimination of the sequence encoding the 4 carboxy-terminal amino acid
residues of PBP1). The excised 2,338-bp EcoRV-RsrII fragment was inserted
between ScaI and RsrII into pDML906.
(vi) pDML908. pDML907 was digested with AscI and RsrII, and the excised
314-bp segment was replaced by oligonucleotide C.
Preparation and protease treatment of spheroplasts of E. coli transformants.
E. coli cells were pelleted and resuspended in 15 mM Tris-HCl (pH 8.0) con-
taining 12.5% (wt/vol) sucrose at a concentration of 2 3 1010 cells per ml. The
cell suspensions were then treated with lysozyme (2 mg/ml)-EDTA (5 mM) in the
same buffer for 25 min at 308C. Under these conditions, all the cells were
converted to spheroplasts.
Spheroplasts were incubated at 308C for 25 min with proteinase K at final
concentrations ranging from 0.016 to 2 mg/ml. Digestion was stopped by adding
100 mM phenylmethylsulfonyl fluoride. Lysis was not observed during this treat-
ment. Samples were then denatured and fractionated on 10% sodium dodecyl
sulfate (SDS) gels. The proteins were electrophoretically transferred to a nitro-
cellulose membrane.
Preparation of plasma membranes of E. coli transformants. E. coli cells
collected from 250-ml isopropyl-b-D-thiogalactopyranoside (IPTG)-induced cul-
tures (optical density at 600 nm of about 1.0) were resuspended in 10 ml of 10
mM Tris-HCl (pH 7.4)–1 mM MgCl2. The suspensions were supplemented with
1 mg of DNase per ml and sonicated at 200 W for 2 min. After centrifugation at
10,000 3 g for 15 min to remove the unbroken cells and debris, the membranes
were isolated by centrifugation at 100,000 3 g for 30 min. They were washed
twice and stored at2208C in the above buffer at a concentration of 20 mg of total
proteins per ml.
Purification of membrane-bound His tag-labelled PBP1 derivatives. Mem-
branes (20 mg of total proteins) were suspended in 20 ml of 30 mM potassium
phosphate (pH 7.6)–0.5 M NaCl–2% cetyltrimethylammonium bromide (CTAB)
and maintained for 30 min at 378C with occasional shaking. After centrifugation
at 100,000 3 g for 30 min, the supernatant was loaded on a 2-ml Ni21-nitrilo-
triacetic acid (NTA) agarose column (Affiland, Lie`ge, Belgium) equilibrated with
the above phosphate-CTAB-NaCl buffer. The column was washed with 50 mM
imidazole, pH 7.4. Elution was carried out with 100 mM imidazole buffer (pH
7.4) containing 2% CTAB.
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Anti-M. leprae PBP1 antibodies and Western blotting (immunoblotting). Pu-
rified PBP1 (100 mg) was injected subcutaneously with incomplete Freund’s
adjuvant into one male rabbit. Successive injections of 40 mg each with incom-
plete Freund’s adjuvant were repeated at the end of the second, third, and fourth
weeks; bleeding was done at the end of the fifth week. Western blotting using
anti-PBP1 antibodies at a dilution of 1:5,000 was performed according to the
Bio-Rad protocol, using horseradish peroxidase-linked anti-rabbit immunoglob-
ulin G as the second antibody and 4-chloro-1-naphthol as the color development
reagent.
Penicillin binding. Isolated membranes and purified PBP1 derivatives were
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE), Coomassie blue
staining, and fluorography of the gels. In this latter case, the protein preparations
were previously labelled with 1 mM [3H]benzylpenicillin (5 Ci/mmol; The Ra-
diochemical Center, Amersham, Buckinghamshire, United Kingdom) for 30 min
at 378C. The values of the second-order rate constant of enzyme penicilloylation
and the first-order rate constant of acyl enzyme breakdown were estimated by
previously described methods (8, 9).
Similarity searches and amino acid sequencing. The algorithms (Pile Up,
Distances, and Plot similarity) were from the Genetics Computer Group package
(2). Automated microsequencing was performed on a 477A pulsed liquid se-
quenator with a one-line 120A PTH-analyzer (Applied Biosystems, Foster City,
Calif.).
RESULTS
Amino acid sequence and molecular organization of M. lep-
rae PBP1. The sequence of cosmid B577 (4a) was corrected for
a frameshift at nucleotide 3437 by dideoxy sequencing reac-
tions using the 21-mer T365-T385 oligonucleotide, an auto-
mated laser fluorescent DNA sequencer, and internal labelling
with fluoro-dATP. The corrected nucleotide sequence con-
tained an open reading frame, called pon1, that encoded the
821-amino-acid-residue multimodular class A PBP1 (Fig. 3).
PBP1 consisted of an M1-I39 pseudo-signal peptide (the
membrane anchor), fused to an S40-A336 non-penicillin-bind-
ing (n-PB) module; the n-PB module was fused to an A337-
A674 penicillin-binding (PB) module, and the PB module was
fused to an M675-D821 carboxy-terminal extension. The n-PB
module contained motifs 1 to 4 common to the multimodular
class A PBPs, and the PB module contained motifs 5 to 7
characteristic of the penicilloyl serine transferase superfamily.
S-398 of motif 5 was assumed to be the active-site serine. Motif
6 was ambiguous, being either S454MN or S464PN. By analogy
with the monofunctional penicilloyl serine transferases, the PB
module was assumed to start about 60 residues upstream from
S-398 of motif 5 and to terminate about 60 residues down-
stream from G-615 of motif 7.
E. coli PBP1a and PBP1b contain 850 and 844 amino acid
residues, respectively. They are regarded as prototypes of the
multimodular class A PBPs because they are the only PBPs
which have been identified as bienzymatic polypeptides per-
forming, in vitro, transglycosylase (the n-PB module) and
transpeptidase (the PB module) activities on isolated disaccha-
ride-peptide lipid II precursors. In contrast to M. leprae PBP1,
E. coli PBP1a contains large inserts occurring at the junctions
between the n-PB and PB modules and between motifs 6 and
7 of the PB module. Similarly, E. coli PBP1b contains large
inserts immediately upstream and downstream from the mem-
brane anchor (7).
For comparison purposes, the inserts and carboxy-terminal
extensions were eliminated from the amino acid sequences. As
a result, the n-PB modules of M. leprae PBP1, E. coli PBP1a,
and E. coli PBP1b contained 296 (S-40 to A-336), 277 (V-42 to
P-319), and 273 (M-186 to P-459) amino acid residues, respec-
tively, and the corresponding PB modules contained 322 (A-
337 to M-659), 309 (Q-412 to P-775 minus the insert from
D-263 to T-677), and 299 (L-461 to P-760) amino acid residues,
respectively. Multisequence amino acid alignment of the n-PB
modules revealed identities of 30% for the PBP1-PBP1a pair
and 27% for the PBP1-PBP1b pair in comparison with 37% for
the PBP1a-PBP1b pair. Alignment of the PB modules revealed
19 to 20% identity for the PBP1-PBP1a and PBP1-PBP1b pairs
in comparison with 29% identity for the PBP1a-PBP1b pair. In
addition, the triad S464PN, not the triad S454MN, of motif 6
of PBP1 aligned with the triad S524KN of PBP1a and the triad
S571MN of PBP1b.
Expression of pon1 in E. coli and properties of PBP1. As M.
FIG. 1. Oligonucleotides used in the construction of plasmids. The peptides
(A, B, and C) and amino acid numbering refer to the sequence shown in Fig. 3.
FIG. 2. Plasmids used for the production of M. leprae PBP1 in E. coli. Oli-
gonucleotides (Oligo) A and B are shown in Fig. 1. Oligonucleotide C was used
to construct pDML908 (not shown; see text).
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leprae is not cultivable, PBP1 is inaccessible to direct investi-
gation. PBP1, with its genuine membrane anchor, was pro-
duced in E. coli, the peptidoglycan of which is of the same
meso-diaminopimelic acid type as that ofMycobacterium sp. To
facilitate the purification, PBP1 was labelled with a polyhisti-
dine [His tag] sequence fused to the amino end of the protein
(plasmid pDML905 encoding [His tag]PBP1).
Expression of the modified pon1 in E. coli BL21 (DE3)/
pDML905 was IPTG inducible and under the control of the T7
promoter and lac operator. Transformants were grown at 378C
in Luria broth containing 50 mg of kanamycin per ml. When an
optical density at 600 nm of 0.5 to 0.6 was reached, 1 mM IPTG
was added and the culture was allowed to grow for 1 more h.
Cell lysis did not occur. The overproduced membrane-bound
[His tag]PBP1 represented about 20% of the total membrane
proteins.
The membrane-bound [His tag]PBP1 had a low affinity for
b-lactam antibiotics. The antibiotic concentrations required to
achieve half-saturation at 378C were 5 3 1025 M for ceftriax-
one, 5 3 1024 M for ampicillin, amoxycillin, and cefoxitin, and
.1023 M for ticarcillin, temocillin, and cephaloridine. The
value of the second-order rate constant of acylation by ben-
zylpenicillin was 5 to 10 M21 s21 in comparison with values of
800 M21 s21 for E. coli PBP1a and 150 M21 s21 for PBP1b.
The penicilloyl-PBP1 intermediate decayed spontaneously
with a first-order rate constant of about 1.7 3 1024 s21 and
therefore had a relatively short half-life of about 90 min. The
penicillin-binding activity of PBP1 had a high thermostability
comparable to that of the E. coli PBP1b, with no loss after 10
min at 608C.
To establish that the bulk of the polypeptide chain of the
membrane-bound [His tag]PBP1 was exposed in the periplasm,
E. coli transformants grown and induced at 378C were con-
verted to spheroplasts and the spheroplasts were treated with
increasing concentrations of proteinase K for 25 min at 308C.
The amount of PBP1 left intact in the protease-treated sphero-
plasts was estimated by SDS-PAGE and Western blotting us-
ing anti-PBP1 antibodies (Fig. 4). The result was that at a
certain concentration of proteinase K, PBP1 could be totally
degraded in intact spheroplasts, showing that the overpro-
duced PBP1 adopted the expected membrane topology.
To check the effects of various levels of pon1 expression on
FIG. 3. Nucleotide sequence of the M. leprae pon1 gene and amino acid sequence of PBP1. Vertical lines define the membrane anchor, the n-PB module, and the
PB module and carboxy-terminal extension of PBP1, respectively. Conserved motifs 1 to 4 (n-PB module) and 5 to 7 (PB module, with some ambiguity for motif 6)
are underlined.
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the folding of PBP1, E. coli transformants were grown under
the same conditions as described above, except that the induc-
tion with IPTG was carried out at 208C, causing a 50% de-
creased production of PBP1 in the membrane from that ob-
tained at 378C. The result was that the membrane topology and
the low penicillin affinity of PBP1 were independent of the
level of gene expression.
[His tag]PBP1 could not be extracted from the membranes
by treatment with 2% Triton X-100, 1% Genapol X-100, 1%
Nonidet P-40, 1% octylglucoside, 1% deoxycholate, or 1%
Sarkosyl. It was solubilized by 2% CTAB–0.5 M NaCl in 10
mM Tris-HCl, pH 7.4. The CTAB-solubilized PBP1 had the
same penicillin affinity as the membrane-bound PBP1. It was
adsorbed on a Ni21-NTA agarose column (Fig. 5). After elu-
tion with 100 mM imidazole in Tris-HCl (pH 7.4)–2% CTAB
and acetone precipitation (7 volumes), SDS-PAGE revealed
the presence of a single protein with the expected molecular
mass. The purified protein bound penicillin with the same low
affinity as the membrane-bound [His tag]PBP1. Upon storage,
degradation products were observed.
Attempts at obtaining water-soluble, truncated forms of
PBP1 in the periplasm of E. coli were made. The pseudo-signal
peptide M1-I39 was replaced by the PelB leader peptide, and
the His tag label was fused to the carboxy end of the protein
(plasmid pDML907 encoding PelB[DM1-I39]PBP1[His tag]).
In addition, the pseudo-signal peptide was replaced by the
PelB leader peptide, the last 100 amino acid residues of the
carboxy-terminal extension were eliminated, and the His tag
label was fused at the carboxy end of the truncated protein
(plasmid pDML908 encoding PelB[DM1-I39]PBP1[DG722-
D821][His tag]). Upon induction at 378C, the E. coli transfor-
mants produced large amounts of PBPs, but contrary to the
expectations, the truncated forms of PBP1 each remained
bound or associated with the plasma membrane. Amino acid
sequencing of the doubly truncated [DM1-I39]PBP1[DG722-
D821][His tag], purified by chromatography on Ni21-NTA
agarose, showed that the PelB leader sequence was not pro-
cessed.
DISCUSSION
It is known that proteins having 25% or more of their se-
quences in common adopt the same folded structures. At the
same time, an increasing number of proteins that have similar
folds but statistically insignificant sequence similarity are being
revealed. In consequence, a classification which extends the
sequence-based superfamilies to include proteins with similar
three-dimensional structures but no sequence similarity has
been proposed (13).
On the basis of the percentages of identities that they con-
tain, one can be confident that the n-PB module of M. leprae
PBP1 and the n-PB (transglycosylase) module of E. coli PBP1a
and PBP1b adopt a similar fold. The percentages of identities
between the PB modules are below the cutoff borderline of
statistically significant similarity, but the motifs characteristic
of the penicilloyl serine transferases are conserved along the
sequences. In all likelihood, the PB module of the M. leprae
PBP1 also has a folded structure similar to that of the PB
(transpeptidase) module of E. coli PBP1a and PBP1b.
E. coli PBP1a and PBP1b possess inserts that are not present
inM. leprae PBP1, the three PBPs each have different carboxy-
terminal extensions, the inserts and extensions are large
enough to form additional modules having their own folds, and
there is no cross-reaction between E. coli PBP1a or PBP1b and
anti-M. leprae PBP1 antibodies or betweenM. leprae PBP1 and
anti-E. coli PBP1b antibodies. Possibly the inserts and exten-
sions are exposed at the surface of the proteins. They may
affect, one way or another, the transglycosylase and transpep-
tidase activities of the PBPs. As a corollary, the functioning of
PBP1 in cell wall peptidoglycan synthesis in M. leprae may be
different from that of PBP1a and PBP1b in E. coli.
It is not possible to measure the penicillin affinity of the
wild-type PBP1 in M. leprae. Consequently, PBP1 has been
(over)produced in E. coli, with the bulk of the polypeptide
chain exposed on the outer face of the membrane, i.e., with the
correct membrane topology. However, solubilization of the
membrane-bound PBP1 requires CTAB, a denaturing agent of
many PBPs. It raises the possibility that the overexpression of
pon1 may result in the formation of some inclusion bodies. As
discussed below, the bulk of observations and experimental
data support the view that the low penicillin affinity of PBP1 is
not due to the misfolding of the polypeptide chain but, rather,
is a property of the wild-type PBP1.
During membrane preparation of the E. coli transformants,
the cell lysates are first centrifuged at 10,000 3 g, and there-
fore, the membrane preparations (used to measure the peni-
cillin affinity of PBP1) must be devoid of any inclusion bodies.
The penicillin affinity of PBP1 is independent of the level of
gene expression; it is exactly the same when expression is
carried out at 37 and 208C. The low penicillin affinity of PBP1
is comparable to that of PBP5 in Enterococcus hirae and PBP29
in Staphylococcus aureus (4). Overexpression of the gene en-
FIG. 4. Protease digestion of PBP1 in spheroplasts. Spheroplasts of E. coli
BL21 (DE3) harboring pDML905 were incubated with proteinase K as described
in Materials and Methods at concentrations of 0, 16, 40, 80, 200, 400, and 2,000
mg/ml. Samples were fractionated by SDS-PAGE, transferred to nitrocellulose
membranes, and probed with anti-PBP1 antibodies. The arrow indicates the
position of PBP1. The relative mobilities of molecular mass markers are indi-
cated to the right of the gel.
FIG. 5. Overproduction of the M. leprae membrane-bound [His tag]PBP1 in
E. coli BL21 (DE3)/pDML905 and purification of the CTAB-solubilized PBP1.
The membranes and proteins were analyzed by SDS-PAGE. Lanes 1 to 4 contain
membranes (2 mg of proteins) isolated from noninduced (lanes 1 and 3) and
IPTG-induced (lanes 2 and 4) cells. Lanes 1 and 2 show PBP patterns after
fluorography. The membranes were labelled with 1 mM [3H]benzylpenicillin for
30 min at 378C before electrophoresis; the gels were exposed for 2 days. Lanes
3 and 4 show protein patterns after Coomassie blue staining. Lane 5 contains the
soluble fraction obtained after 2% CTAB–0.5 M NaCl treatment of membranes
isolated from IPTG-induced cells and after Coomassie blue staining. Lanes 6 and
7 contain Ni21-NTA agarose-purified PBP1 after Coomassie blue staining (lane
6) and fluorography (lane 7). Lane M contains molecular mass markers.
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coding the enterococcal low-affinity PBP5 in laboratory mu-
tants and in E. coli (using expression vectors identical to those
used for pon1) does not alter the penicillin-binding fold topol-
ogy of the overproduced PBP; its penicillin affinity is the same
as that of the wild-type PBP (13a).
The mode of binding of the PBPs to the membrane bilayer
and the effects of the detergents are species specific. CTAB
solubilizes the low-molecular-mass PBP (with DD-transpepti-
dase activity) of Streptomyces sp. strain K15 with preservation
of the penicillin-binding fold topology; the value of the first-
order rate constant of acylation by penicillin is exactly the same
(150 M21 s21) for the wild-type membrane-bound enzyme and
the CTAB-extracted enzyme (11). X-ray crystallography stud-
ies suggest that a secondary structure at the surface of the
protein might function as a membrane association site (1a). E.
coli PBP1b also possesses at least one membrane association
site in addition to the amino-terminal transmembrane anchor
(12). PBP1b is stable and active in Sarkosyl, a denaturing
detergent for the other PBPs.
Classical b-lactam antibiotics are not effective agents for the
treatment of leprosy. Yet, in the mouse footpad model, cefox-
itin has low 90% inhibitory dose values (15), and ampicillin in
combination with a b-lactamase inhibitor prevents growth of
M. leprae strains, including strains resistant to dapsone or ri-
fampin (14). The fact that PBP1 has a low penicillin affinity
does not necessarily contradict these observations, since M.
leprae may possess other essential PBPs that may be suscepti-
ble to penicillin action. A gene that is provisionally called pon2
and encodes a second high-molecular-mass class A PBP is
present in cosmid L222 of the M. leprae library (unpublished
data). This situation is reminiscent of ponA (encoding PBP1a)
and ponB (encoding PBP1b) in E. coli. Deletion of ponA and
ponB is fatal, but deletion of either ponA or ponB is tolerated,
suggesting that one PBP can compensate for the other (17).
Counterparts of the multimodular class B PBP2 and PBP3 of
E. coli may also be present in M. leprae. These PBPs are key
components of morphogenetic networks involved in cell sep-
tation and cell shape maintenance (7). In E. coli, PBPs are
major killing targets of b-lactam antibiotics.
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